Merck & Co Inc (NYSE:MRK)

73.43
Delayed Data
As of 4:02pm ET
 +0.09 / +0.12%
Today’s Change
68.38
Today|||52-Week Range
91.40
-5.86%
Year-to-Date
Why Vaccine Stocks Like BioNTech and Novavax Are Crashing Today
4:19pm / MotleyFool.com - Paid Partner Content
Merck (MRK) Up as COVID Pill Gets FDA Panel's Positive Vote
Dec 01 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Expanded Melanoma Use
11:45am / Zacks.com - Paid Partner Content
Adagene (ADAG) Gets FDA Nod to Begin Solid Tumor Antibody Study
Nov 30 / Zacks.com - Paid Partner Content
Bristol Myers (BMY) sBLA for Reblozyl Gets Priority Review
9:01am / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets Europe Nod for Two Carcinomas
Nov 30 / Zacks.com - Paid Partner Content
J&J, Pfizer, Novartis Among Pharma Giants With Biggest War Chests
Dec 05 / GuruFocus News - Paid Partner Content
Stock Market News for Nov 30, 2021
Nov 30 / Zacks.com - Paid Partner Content
Here's Why Merck Lost Nearly $40 Billion in Value During November
Dec 04 / MotleyFool.com - Paid Partner Content
Why Merck Stock Is Slipping Today
Nov 29 / MotleyFool.com - Paid Partner Content
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
Dec 04 / MotleyFool.com - Paid Partner Content
Bristol Myers (BMY) Top Drugs Maintain Momentum Amid Competition
Nov 29 / Zacks.com - Paid Partner Content
Here's Why The New Coronavirus Variant Won't Harm Pfizer's Stock
Dec 03 / MotleyFool.com - Paid Partner Content
Merck (MRK) COVID Pill Less Effective in Final Study, Stock Down
Nov 29 / Zacks.com - Paid Partner Content
Aurinia (AUPH) Stock Up on Potential Acquisition Rumors
Dec 03 / Zacks.com - Paid Partner Content
Who Would Be the Best FDA Commissioner for Biotech Investors?
Nov 28 / MotleyFool.com - Paid Partner Content
Merck's Selloff Is an Overreaction
Dec 03 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: FDA Nod to COVID Jab for All Adults, CHMP Nod to Shot for Kids
Nov 26 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA Panel Vote for MRK COVID Pill, JNJ Omicron Jab Plan
Dec 03 / Zacks.com - Paid Partner Content
Gilead (GILD) Gets EU Nod for Breast Cancer Drug, Trodelvy
Nov 24 / Zacks.com - Paid Partner Content
3 Stocks to Buy for the New COVID Variant
Dec 02 / MotleyFool.com - Paid Partner Content
Bristol Myers (BMY) Zeposia Gets EC Nod for Ulcerative Colitis
Nov 24 / Zacks.com - Paid Partner Content
Merck, Novartis in Line for Key FDA Approvals This Month
Dec 02 / GuruFocus News - Paid Partner Content
Why You Can't Afford Not to Buy Merck's Stock
Nov 23 / MotleyFool.com - Paid Partner Content
Merck (MRK) Vaxneuvance sBLA for Pediatrics Gets Priority Review
Dec 02 / Zacks.com - Paid Partner Content
4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock
Nov 23 / MotleyFool.com - Paid Partner Content
4 Dependable Healthcare Stocks to Buy Hand Over Fist Right Now
Dec 01 / StockNews.com - Paid Partner Content
Mirati (MRTX), Verastem to Study Cancer Drugs for NSCLC
Nov 23 / Zacks.com - Paid Partner Content
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
Dec 01 / MotleyFool.com - Paid Partner Content
Will Investors Benefit From Johnson & Johnson's Breakup?
Nov 23 / MotleyFool.com - Paid Partner Content
AstraZeneca, Merck's Lynparza sNDA Gets FDA Priority Tag
Dec 01 / Zacks.com - Paid Partner Content
Why giant companies are suddenly splitting into pieces
Nov 12 / CNN.com